BDBM164883 US9067888, 33

SMILES COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@H](C2)NC(C)=O)c1

InChI Key InChIKey=QNWXRLPZIFMTBK-DOTOQJQBSA-N

Data  21 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 164883   

TargetCyclin-dependent kinase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  94nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCyclin-dependent kinase 3(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  219nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCyclin-dependent kinase 5(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  1.08E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCyclin-dependent kinase 6(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCyclin-dependent kinase 7(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetGlycogen synthase kinase-3 alpha(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  160nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  903nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetInterleukin-1 receptor-associated kinase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCyclin-dependent kinase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  168nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent